In2Pharma
  • Home
  • Services
    • Regulatory Affairs
    • Quality Assurance
    • Publicity and Compliance
    • Medical writing & training
    • Vigilance
  • About Us
  • News
  • Contact
Select Page
Update notification form “Meldpunt geneesmiddelentekorten en -defecten”

Update notification form “Meldpunt geneesmiddelentekorten en -defecten”

by In2Pharma | Oct 10, 2024 | News

The Netherlands As of 25 October 2024, a new version of the notification form of the “Meldpunt geneesmiddelentekorten en -defecten” will become available. The new form will include the following changes: The addition of the option to adjust the period indication of a...

Recent Posts

  • Update Notification Form “Meldpunt”
  • Planned legislative updates NL
  • Update RD 06.09.2017 pregabalin/gabapentin
  • Update New Inspection Platform GDP – FAMHP
  • Luxembourg tightens rules on nicotine pouches and novel nicotine products from 2026  

Follow Us

  • Facebook
  • LinkedIn
An IQVIA Business

IQVIA Logo
IQVIA is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries and is dedicated to delivering actionable insights and accelerating innovations.

www.iqvia.com

Contact Us

Privacy Policy | Your Privacy Choices | Cookie Policy | BTW BE 895730662 | +32 16 89 16 00| info@in2pharma.com |Terloonststraat 22, 1910 Kampenhout, België